Role of Biologic Response Modifiers in the Growth and Differentiation of Myeloid Leukemic Cells
- 1 January 1989
- book chapter
- Published by Springer Nature
- Vol. 149, 165-172
- https://doi.org/10.1007/978-3-642-74623-9_16
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expressionBlood, 1987
- 1,25‐dihydroxycholecalciferol‐induced differentiation of myelomonocytic leukemic cells unresponsive to colony stimulating factors and phorbol estersJournal of Cellular Physiology, 1986
- Transforming Growth Factor-β: Biological Function and Chemical StructureScience, 1986
- Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemiaBlood, 1986
- Binding of the differentiation-inducer, granulocyte-colony-stimulating factor, to responsive but not unresponsive leukemic cell lines.Proceedings of the National Academy of Sciences, 1984
- 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cellsLeukemia Research, 1983
- The nature and action of granulocyte-macrophage colony stimulating factorsBlood, 1980
- T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor.Proceedings of the National Academy of Sciences, 1980
- Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.The Journal of Experimental Medicine, 1976